Journal article
The challenges of introducing routine G6PD testing into radical cure: A workshop report
B Ley, N Luter, FE Espino, A Devine, M Kalnoky, Y Lubell, K Thriemer, JK Baird, E Poirot, N Conan, CC Kheong, L Dysoley, WA Khan, AG Dion-Berboso, G Bancone, J Hwang, R Kumar, RN Price, L Von Seidlein, GJ Domingo
Malaria Journal | BMC | Published : 2015
Abstract
The only currently available drug that effectively removes malaria hypnozoites from the human host is primaquine. The use of 8-aminoquinolines is hampered by haemolytic side effects in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. Recently a number of qualitative and a quantitative rapid diagnostic test (RDT) format have been developed that provide an alternative to the current standard G6PD activity assays. The WHO has recently recommended routine testing of G6PD status prior to primaquine radical cure whenever possible. A workshop was held in the Philippines in early 2015 to discuss key challenges and knowledge gaps that hinder the introduction of routine G6PD testing. Tw..
View full abstractGrants
Funding Acknowledgements
We would like to thank all participants of the workshop and RITM for hosting this event and Ms. Kylie Mannion for logistic support. The workshop has been funded by the Asia Pacifica Malaria Elimination Network (APMEN) and PATH.